Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2b and ribavirin for recurrent hepatitis C.

Mukherjee, Sandeep

Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2b and ribavirin for recurrent hepatitis C. [electronic resource] - Journal of gastroenterology and hepatology Jun 2004 - 723-4 p. digital

Publication Type: Case Reports; Letter

0815-9319

10.1111/j.1440-1746.2004.03452.x doi


Adult
Antiviral Agents--adverse effects
Chemical and Drug Induced Liver Injury
Female
Hepatitis C--drug therapy
Humans
Interferon alpha-2
Interferon-alpha--adverse effects
Male
Polyethylene Glycols
Recombinant Proteins
Recurrence
Ribavirin--adverse effects